Evidence map›Paper›PMID 27307423›Full record

ArticleLaboratory animals2017

Does age matter? The impact of rodent age on study outcomes.

Samuel J Jackson, Nick Andrews, Doug Ball, Ilaria Bellantuono, James Gray, Lamia Hachoumi, Alan Holmes, Judy Latcham, Anja Petrie, Paul Potter and 6 more

Abstract read
In one paragraph

Article in Laboratory animals, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 228 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
228citing papers in PubMed, 15 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

228 citing papers in PubMed, 15 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Preclinical Large AnimalCurrent cardiology reviews · 2023
    Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

168 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Samuel J Jackson1 National Centre for the Replacement, Refinement and Reduction of Animals in Research, London, UK.
Nick Andrews2 Division of Neurology, Kirby Center for Neurobiology, Boston Children's Hospital, Boston, US.
Doug Ball3 Immunoinflammation TAU, GlaxoSmithKline, Stevenage, UK.
Ilaria Bellantuono4 Centre for Integrated Research into Musculoskeletal Ageing, University of Sheffield, Sheffield, UK.
James Gray3 Immunoinflammation TAU, GlaxoSmithKline, Stevenage, UK.
Lamia Hachoumi5 Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK.
Alan Holmes6 Centre for Rheumatology, UCL Division of Medicine, Royal Free Campus, London, UK.
Judy Latcham7 Laboratory Animal Science, GlaxoSmithKline, Stevenage, UK.
Anja Petrie8 Rowett Institute of Nutrition & Health, University of Aberdeen, Aberdeen, UK.
Paul Potter9 Disease Models and Translation, Mammalian Genetics Unit, MRC Harwell, Harwell, UK.
Andrew Rice10 Pain Research, Department of Surgery & Cancer, Imperial College London, London, UK.
Alison Ritchie11 Division of Cancer & Stem Cells, University of Nottingham, Nottingham, UK.
Michelle Stewart12 The Mary Lyon Centre, MRC Harwell, Harwell, UK.
Carol Strepka13 Preclinical Services, Charles River, Edinburgh, UK.
Mark Yeoman5 Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK.
Kathryn Chapman1 National Centre for the Replacement, Refinement and Reduction of Animals in Research, London, UK.

Funding

Medical Research Council MC_U142684172Medical Research Council MC_UP_1502/1Medical Research Council MR/K006312/1
6 · The paper itself

Abstract

Rodent models produce data which underpin biomedical research and non-clinical drug trials, but translation from rodents into successful clinical outcomes is often lacking. There is a growing body of evidence showing that improving experimental design is key to improving the predictive nature of rodent studies and reducing the number of animals used in research. Age, one important factor in experimental design, is often poorly reported and can be overlooked. The authors conducted a survey to assess the age used for a range of models, and the reasoning for age choice. From 297 respondents providing 611 responses, researchers reported using rodents most often in the 6-20 week age range regardless of the biology being studied. The age referred to as 'adult' by respondents varied between six and 20 weeks. Practical reasons for the choice of rodent age were frequently given, with increased cost associated with using older animals and maintenance of historical data comparability being two important limiting factors. These results highlight that choice of age is inconsistent across the research community and often not based on the development or cellular ageing of the system being studied. This could potentially result in decreased scientific validity and increased experimental variability. In some cases the use of older animals may be beneficial. Increased scientific rigour in the choice of the age of rodent may increase the translation of rodent models to humans.

Indexed as

AgingAge FactorsAnimalsBiomedical ResearchMiceRatsTerminology as Topicagedevelopmentexperimental designrodentsenescence

Identifiers

PMID27307423
PMCPMC5367550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.